Recent Advances in New Discovered Molecular Targets in Testicular Germ Cell Tumors

Author(s): Paolo Chieffi*

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 5 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Background: Testicular germ cell tumor (TGCT) is the most common solid malignancy occurring in young men between 20 and 34 years of age, and its incidence has increased significantly over the last decades. TGCTs can be subdivided into seminoma and nonseminoma germ cell tumors (NSGCTs), which includes yolk sac tumor, choriocarcinoma, embryonal cell carcinoma, and teratoma. Seminomas and NSGCTs present significant differences in therapy, prognosis, and both show characteristics of the Primordial Germ Cells (PGCs).

Methods: I undertook a search of bibliographic data from peer-reviewed research literature.

Results: Seventy papers were included in the mini-review showing that a large number of new biomarkers have given further advantages to discriminate the different histotypes and could represent useful novel molecular targets for anticancer strategies.

Conclusion: A deeper understanding of the pathogenesis of TGCTs is likely to significantly improve not only our knowledge on stem cells and oncogenesis but also the disease management with more selective tumor treatment.

Keywords: Testicular germ cells tumors, seminomas, Aurora B, GPR30, PATZ1, HMGA.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 03 October, 2017
Page: [575 - 583]
Pages: 9
DOI: 10.2174/0929867324666171003115807
Price: $65

Article Metrics

PDF: 46
HTML: 20
PRC: 1